CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill ...
Eli Lilly (LLY) just did something worth paying attention to. With CVS Caremark announcing coverage of both Zepbound and ...
The pharmacy benefit manager dropped Zepbound a year ago in favor of rival Wegovy — now both Lilly and Novo Nordisk drugs ...
Eli Lilly and Company (NYSE:LLY) is one of the best stocks to buy now for long term growth. Eli Lilly and Company (NYSE:LLY) ...
By Sriparna Roy May 28 (Reuters) - CVS Health will restore Eli Lilly's weight-loss injection Zepbound to its list of covered ...
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
Eli Lilly and Company (NYSE:LLY) shares gained about 1% in premarket trading Thursday after CVS Caremark announced it would ...
The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, ...
(CNN)– CVS is adding two weight-loss options to its drug plans. CVS Health said it will start coverage of Lilly’s anti-obesity pill, June 1. And it’s reinstating coverage of Eli Lilly’s weight-loss ...
CVS Health will restore Eli Lilly’s weight-loss injection Zepbound to its list of covered drugs and also add the drugmaker’s ...
CVS Health has announced a significant expansion of its coverage for Eli Lilly's weight-loss medications, confirming it will ...
Eli Lilly shares hit a new all-time closing high on news of increased insurance coverage for its blockbuster weight-loss drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results